Quest Diagnostics' connectivity products are used by more than 115,000 physicians nationwide. Its large user base provides an opportunity to dramatically drive market penetration and physician utilization of electronic prescribing.
Electronic access to both lab and prescription data enables physicians to improve patient care, more easily participate in pay-for-performance programs, and increase the efficiency of their practices.
Interested prescribers can visit the NEPSI web site, http://www.nationaleRx.com, to register for eRx NOW or Quest Diagnostics' Care360 Physician Portal website, http://www.questdiagnostics.com/Care360 to request the Care360 Physician Portal.
The National ePrescribing Patient Safety Initiative (NEPSI) is a
coalition of the nation's most prominent technology companies and leading
healthcare organizations dedicated to improving patient safety by providing
free access to simple, safe and secure electronic prescribing for every
physician in America. The coalition is led by Allscripts (Nasdaq: MDRX) and
national sponsor Dell, as well as sponsors Aetna, Cisco Systems, eRx
Networks, Fujitsu, Google, Microsoft, NaviMedix, Quest Diagnostics, Sprint
Nextel, Smart ID Works, SureScripts, WellPoint, and Wolters Kluwer Health.
The NEPSI offering also is supported by a growing number of academic
medical centers, integrated delivery networks and physician groups across
the U.S. who are leading the rollout of the NEPSI electronic prescribing
solution, eRx NOW, within their states and regions. For more i
|SOURCE Quest Diagnostics Incorporated|
Copyright©2007 PR Newswire.
All rights reserved